Interplay between triglyceride-glucose index and cardiovascular events in hypertensive patients with controlled blood pressure (SBP<140 mmHg): insights from the SPRINT trial
IntroductionHypertension significantly contributes to cardiovascular events and global all-cause mortality. The triglyceride-glucose (TyG) index, amarker of insulin resistance (IR), is an established risk factor for cardiovascular disease (CVD) events. This study examined the relationship between th...
Saved in:
Main Authors: | , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2025-07-01
|
Series: | Frontiers in Endocrinology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fendo.2025.1508667/full |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|